T. Rowe Price Associates’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $33K | Sell |
|
|||||
|
2024
Q4 | $1.58M | Sell |
|
|||||
|
2024
Q3 | $4.13M | Sell |
|
|||||
|
2024
Q2 | $5.68M | Sell |
|
|||||
|
2024
Q1 | $35.9M | Buy |
|
|||||
|
2023
Q4 | $278K | Sell |
|
|||||
|
2023
Q3 | $154K | Buy |
|
|||||
|
2023
Q2 | $134K | Buy |
|
|||||
|
2023
Q1 | $178K | Buy |
|
|||||
|
2022
Q4 | $159K | Buy |
|
|||||
|
2022
Q3 | $63K | Sell |
|
|||||
|
2022
Q2 | $74K | Buy |
|
|||||
|
2022
Q1 | $218K | Buy |
|
|||||
|
2021
Q4 | $373K | Sell |
|
|||||
|
2021
Q3 | $785K | Buy |
|
|||||
|
2021
Q2 | $888K | Sell |
|
|||||
|
2021
Q1 | $1.05M | Buy |
|
|||||
|
2020
Q4 | $672K | Buy |
|
|||||
|
2020
Q3 | $436K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $28.6M | Sell |
|
|||||
|
2018
Q3 | $49M | Buy |
|
|||||
|
2018
Q2 | $46.2M | Sell |
|
|||||
|
2018
Q1 | $56.8M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $251K | Hold |
|
|||||
|
2016
Q2 | $226K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $1.14M | Buy |
|